10 páginas, 5 figuras, 2 tablas.-- et al.The immunopathogenesis of type I autoimmune hepatitis (AIH-I) might involve the deregulation of different cellular processes. Here, we investigated the liver expression of selected cytokines and genes of regulatory cell populations in children both at diagnosis and during biochemical remission following immunosuppressive treatment (AIH-Ir). We found a higher Vα24, IFN-γ, FoxP3, IL-27p28, IL-12p40 and IL-21 expression at diagnosis as well as a positive correlation between IL-21 and transaminase levels. Interestingly, only IFN-γ and FoxP3 were decreased in AIH-Ir. An “AIH-I phenotype” (high Vα24, IFN-γ and FoxP3 expression at diagnosis) was observed in only 5 out of 22 AIH-Ir patients but not in contro...
Clinical manifestations of autoimmune hepatitis (AIH) range from mild chronic to acute, sometimes fu...
A subset of human regulatory T cells (Tregs) can secrete IFN-γ or IL-17 and thus share features of T...
Background and Aim: T cell expression of PD1 and inhibition of T effector cells by Foxp3(+)-T regula...
The immunopathogenesis of type I autoimmune hepatitis (AIH-I) might involve the deregulation of diff...
This study is aimed at examining the potential role of regulatory T- (Treg-) Th1-Th17-Th22 cells in ...
Background. T-cell populations regulate the balance of immune responses. The CD (Cluster of differen...
The autoimmune hepatitis (AIH) is a chronic hepatitis driven by the adaptive immunity that affects a...
International audienceAutoimmune hepatitis (AIH) is a rare disease characterized by an immune attack...
BACKGROUND & AIMS: The pathogenesis of autoimmune hepatitis (AIH) is not understood, but it was sugg...
Autoimmune hepatitis (AIH) is a severe and unresolving inflammatory disease of the liver, of unknown...
Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease caused by a perturbed immune sys...
Autoimmune hepatitis is an immuno-mediated inflammatory liver disorder of unknown etiology and is ch...
Autoimmune hepatitis (AIH) is a chronic inflammatory disorder characterized by hypergammaglobulinemi...
Background and aims. Autoimmune hepatitis (AIH) is a chronic inflammatory condition of the liver in ...
Immune checkpoint molecules (ICM) are critical in maintaining immunologic homeostasis and participat...
Clinical manifestations of autoimmune hepatitis (AIH) range from mild chronic to acute, sometimes fu...
A subset of human regulatory T cells (Tregs) can secrete IFN-γ or IL-17 and thus share features of T...
Background and Aim: T cell expression of PD1 and inhibition of T effector cells by Foxp3(+)-T regula...
The immunopathogenesis of type I autoimmune hepatitis (AIH-I) might involve the deregulation of diff...
This study is aimed at examining the potential role of regulatory T- (Treg-) Th1-Th17-Th22 cells in ...
Background. T-cell populations regulate the balance of immune responses. The CD (Cluster of differen...
The autoimmune hepatitis (AIH) is a chronic hepatitis driven by the adaptive immunity that affects a...
International audienceAutoimmune hepatitis (AIH) is a rare disease characterized by an immune attack...
BACKGROUND & AIMS: The pathogenesis of autoimmune hepatitis (AIH) is not understood, but it was sugg...
Autoimmune hepatitis (AIH) is a severe and unresolving inflammatory disease of the liver, of unknown...
Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease caused by a perturbed immune sys...
Autoimmune hepatitis is an immuno-mediated inflammatory liver disorder of unknown etiology and is ch...
Autoimmune hepatitis (AIH) is a chronic inflammatory disorder characterized by hypergammaglobulinemi...
Background and aims. Autoimmune hepatitis (AIH) is a chronic inflammatory condition of the liver in ...
Immune checkpoint molecules (ICM) are critical in maintaining immunologic homeostasis and participat...
Clinical manifestations of autoimmune hepatitis (AIH) range from mild chronic to acute, sometimes fu...
A subset of human regulatory T cells (Tregs) can secrete IFN-γ or IL-17 and thus share features of T...
Background and Aim: T cell expression of PD1 and inhibition of T effector cells by Foxp3(+)-T regula...